Pay in 4 interest-free payments of $6.60 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Kahn SE, Haffner SM, Heise MA, et al
Tirzepatide is a next-generation medication designed to support weight loss by targeting multiple pathways involved in appetite and metabolism
Studies show that patients who rotate injection sites experience more predictable dose response compared to those who inject in the same location repeatedly
It can also help to stabilise your blood sugar levels by increasing insulin production
This innermost part of the skin is above the muscle layer and has comparatively less blood flow, allowing the medicine to be absorbed more slowly compared to intravenous (IV, or into a vein) injections and intramuscular (IM, or into a muscle) injections
The Phase 2 trial of eloralintide was reported in The Lancet
